NCT02982798View on ClinicalTrials.gov

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

August 30, 2017

Study Completion Date

January 31, 2018

Conditions
DiabetesHyperlipidemia
Interventions
DRUG

Metformin + Rosuvastatin

administration of Metformin + Rosuvastatin

DRUG

JLP-1310

administration of JLP-1310

Trial Locations (1)

Unknown

Inha University Hospital, Incheon

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY